​
​

Cytosorbents (CTSO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Cytosorbents Revenue Highlights

Latest Revenue (Y)

$36.35M

Latest Revenue (Q)

$8.61B

Main Segment (Y)

Grant income

Main Geography (Y)

All other countries

Cytosorbents Revenue by Period

Cytosorbents Revenue by Year

DateRevenueChange
2023-12-31-23.81%
2022-12-31--26.80%
2021-12-31-1.66%
2020-12-31-73.30%
2019-12-31-12.41%
2018-12-31-51.34%
2017-12-31-63.07%
2016-12-31-102.33%
2015-12-31-28.96%
2014-12-31-282.70%
2013-12-31-442.17%
2012-12-31-320.13%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31--100.00%
2005-05-31--

Cytosorbents generated $36.35M in revenue during NA 2023, up 23.81% compared to the previous quarter, and up 179.48% compared to the same period a year ago.

Cytosorbents Revenue by Quarter

DateRevenueChange
2024-09-30-86945.09%
2024-06-30-1.11%
2024-03-31-12.90%
2023-12-31-11.79%
2023-09-30--3.94%
2023-06-30-2.05%
2023-03-31-3.51%
2022-12-31-18.25%
2022-09-30--11.84%
2022-06-30--7.49%
2022-03-31--18.29%
2021-12-31-8.94%
2021-09-30--21.68%
2021-06-30-12.05%
2021-03-31--12.03%
2020-12-31-12.54%
2020-09-30-7.62%
2020-06-30-16.73%
2020-03-31-23.38%
2019-12-31-15.40%
2019-09-30--2.09%
2019-06-30-27.83%
2019-03-31--16.35%
2018-12-31-7.21%
2018-09-30--2.72%
2018-06-30-18.32%
2018-03-31-3.19%
2017-12-31-24.57%
2017-09-30-13.41%
2017-06-30-17.14%
2017-03-31--0.64%
2016-12-31-21.92%
2016-09-30-15.68%
2016-06-30-15.98%
2016-03-31-6.81%
2015-12-31-39.58%
2015-09-30-36.62%
2015-06-30-11.33%
2015-03-31--19.36%
2014-12-31--15.53%
2014-09-30-55.36%
2014-06-30-16.61%
2014-03-31-81.73%
2013-12-31-54.33%
2013-09-30-59.07%
2013-06-30--27.33%
2013-03-31--130.00%
2012-12-31--196.98%
2012-09-30-1732.05%
2012-06-30-95.60%
2012-03-31--53.18%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--

Cytosorbents generated $8.61B in revenue during Q3 2024, up 86945.09% compared to the previous quarter, and up 106694.19% compared to the same period a year ago.

Cytosorbents Revenue Breakdown

Cytosorbents Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Other sales-----
Grant income-----
Cyto Sorb Sales-----
Other Sales-----

Cytosorbents's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant income (98.69%), and Other sales (1.31%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Grant income--------------------
Other sales--------------------
Cyto Sorb Sales--------------------
Other product sales--------------------
Other Sales--------------------

Cytosorbents's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant income (96.70%), and Other sales (3.30%).

Cytosorbents Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
United States-----
All other countries-----
Germany-----
U-----
All Other Countries-----
D-----

Cytosorbents's latest annual revenue breakdown by geography, as of Dec 23: All other countries (49.76%), Germany (35.73%), and United States (14.51%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Germany--------------------
United States--------------------
All other countries--------------------
All Other Countries--------------------
U--------------------
D--------------------

Cytosorbents's latest quarterly revenue breakdown by geography, as of Sep 24: All other countries (57.75%), Germany (33.95%), and United States (8.30%).

Cytosorbents Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova--
AORTArtivion--
INGNInogen--
FNAParagon 28--
KIDSOrthoPediatrics--
SRDXSurmodics--
LUNGPulmonx--
NPCENeuroPace--
TELATELA Bio--
APYXApyx Medical--
CVRXCVRx--
CTSOCytosorbents--
OSAProSomnus--
CLPTClearPoint Neuro--
OFIXOrthofix Medical--

CTSO Revenue FAQ

What is Cytosorbents’s yearly revenue?

Cytosorbents's yearly revenue for 2023 was $36.35M, representing an increase of 23.81% compared to 2022. The company's yearly revenue for 2022 was $29.36M, representing a decrease of -26.80% compared to 2021. CTSO's yearly revenue for 2021 was $40.11M, representing an increase of 1.66% compared to 2020.

What is Cytosorbents’s quarterly revenue?

Cytosorbents's quarterly revenue for Q3 2024 was $8.61B, a 86945.09% increase from the previous quarter (Q2 2024), and a 110975.51% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $9.89M, a 1.11% increase from the previous quarter (Q1 2024), and a 22.57% increase year-over-year (Q2 2023). CTSO's quarterly revenue for Q1 2024 was $9.79M, a 12.90% increase from the previous quarter (Q4 2023), and a 23.72% increase year-over-year (Q1 2023).

What is Cytosorbents’s revenue growth rate?

Cytosorbents's revenue growth rate for the last 3 years (2021-2023) was -9.37%, and for the last 5 years (2019-2023) was 59.67%.

What are Cytosorbents’s revenue streams?

Cytosorbents's revenue streams in c 23 are Other sales, and Grant income. Other sales generated $69.68K in revenue, accounting 1.31% of the company's total revenue, down -91.15% year-over-year. Grant income generated $5.26M in revenue, accounting 98.69% of the company's total revenue

What is Cytosorbents’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cytosorbents was Grant income. This segment made a revenue of $5.26M, representing 98.69% of the company's total revenue.